ANDA 214831

ANNORA PHARMA

FDA Drug Application

Application #214831

Application Sponsors

ANDA 214831

ANNORA PHARMA

Marketing Status

• None (Tentative Approval): 001
• None (Tentative Approval): 002
• None (Tentative Approval): 003
• None (Tentative Approval): 004
• None (Tentative Approval): 005

Application Products

002	TABLET; ORAL	25mg	0	BRIVARACETAM	BRIVARACETAM
003	TABLET; ORAL	50mg	0	BRIVARACETAM	BRIVARACETAM
004	TABLET; ORAL	75mg	0	BRIVARACETAM	BRIVARACETAM
005	TABLET; ORAL	100mg	0	BRIVARACETAM	BRIVARACETAM

FDA Submissions

UNKNOWN;

ORIG

1

TA

2022-06-01

STANDARD

Submissions Property Types

ORIG

1

Null

31

CDER Filings

Accessdata Error

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214831
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)